Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] ALL
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6403 6404 6405 6406 6407 6408 6409 6410 6411 6412 6413 6414 6415 6416 6417 6418 6419 6420 6421 6422 6423 6424 6425 6426 6427 6428 6429 6430 6431 6432 6433 6434 6435 6436 6437 6438 6439 6440 6441 6442 6443 … 6470 6471 6472 6473 6474 6475 6476 6477 6478 6479 6480 6481 6482 6483 6484 6485 6486 6487 6488 6489 Next Last
#
NCTID/Status
Study
Last Changed
321101
NCT00002209
Completed
Completed
Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy
Conditions: AIDS Dementia Complex; HIV Infections
Intervention: CPI-1189
Conditions: AIDS Dementia Complex; HIV Infections
Intervention: CPI-1189
June 23, 2005
321102
NCT00002208
Completed
Completed
A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC
Conditions: HIV Infections
Intervention: Indinavir Sulfate, Lamivudine, Stavudine, Zidovudine
Conditions: HIV Infections
Intervention: Indinavir Sulfate, Lamivudine, Stavudine, Zidovudine
June 23, 2005
321103
NCT00002207
Completed
Completed
A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients
Conditions: HIV Infections
Intervention: Stavudine, Didanosine
Conditions: HIV Infections
Intervention: Stavudine, Didanosine
April 13, 2011
321104
NCT00002206
Completed
Completed
A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs
Conditions: HIV Infections
Intervention: Adefovir Dipivoxil
Conditions: HIV Infections
Intervention: Adefovir Dipivoxil
June 23, 2005
321105
NCT00002205
Completed
Completed
An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
Conditions: HIV Infections
Intervention: Abacavir Sulfate, Amprenavir
Conditions: HIV Infections
Intervention: Abacavir Sulfate, Amprenavir
June 23, 2005
321106
NCT00002204
Completed
Completed
A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults
Conditions: HIV Infections; HIV Seronegativity
Intervention: HIV P24/MF59 Vaccine
Conditions: HIV Infections; HIV Seronegativity
Intervention: HIV P24/MF59 Vaccine
June 23, 2005
321107
NCT00002203
Completed
Completed
A Study of Two Anti-HIV Drug Combinations
Conditions: HIV Infections
Intervention: Lamivudine/Zidovudine, Lamivudine, Zidovudine
Conditions: HIV Infections
Intervention: Lamivudine/Zidovudine, Lamivudine, Zidovudine
June 23, 2005
321108
NCT00002202
Completed
Completed
A Comparison of 141W94 and Indinavir in HIV-Infected Patients
Conditions: HIV Infections
Intervention: Indinavir Sulfate, Amprenavir
Conditions: HIV Infections
Intervention: Indinavir Sulfate, Amprenavir
June 23, 2005
321109
NCT00002201
Completed
Completed
A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients
Conditions: HIV Infections
Intervention: Ritonavir, Nelfinavir Mesylate
Conditions: HIV Infections
Intervention: Ritonavir, Nelfinavir Mesylate
February 19, 2009
321110
NCT00002200
Completed
Completed
June 23, 2005
321111
NCT00002199
Completed
Completed
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
Conditions: HIV Infections
Intervention: Indinavir Sulfate, Lamivudine/Zidovudine, Abacavir Sulfate
Conditions: HIV Infections
Intervention: Indinavir Sulfate, Lamivudine/Zidovudine, Abacavir Sulfate
June 23, 2005
321112
NCT00002198
Completed
Completed
A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients
Conditions: HIV Infections
Intervention: Abacavir Sulfate
Conditions: HIV Infections
Intervention: Abacavir Sulfate
June 23, 2005
321113
NCT00002197
Completed
Completed
A Study of 1592U89 in HIV-Infected Children
Conditions: HIV Infections
Intervention: Abacavir Sulfate
Conditions: HIV Infections
Intervention: Abacavir Sulfate
June 23, 2005
321114
NCT00002196
Completed
Completed
June 23, 2005
321115
NCT00002195
Completed
Completed
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
Conditions: HIV Infections
Intervention: Amprenavir, Lamivudine, Zidovudine
Conditions: HIV Infections
Intervention: Amprenavir, Lamivudine, Zidovudine
June 23, 2005
321116
NCT00002194
Completed
Completed
An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.
Conditions: HIV Infections
Intervention: Erythromycin, Nevirapine, Clarithromycin
Conditions: HIV Infections
Intervention: Erythromycin, Nevirapine, Clarithromycin
June 23, 2005
321117
NCT00002193
Completed
Completed
Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors
Conditions: HIV Infections
Intervention: Amprenavir
Conditions: HIV Infections
Intervention: Amprenavir
June 23, 2005
321118
NCT00002192
Completed
Completed
Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.
Conditions: Mycobacterium Avium-Intracellulare Infection; HIV Infections
Intervention: Rifapentine, Ethambutol Hydrochloride, Clarithromycin, Azithromycin
Conditions: Mycobacterium Avium-Intracellulare Infection; HIV Infections
Intervention: Rifapentine, Ethambutol Hydrochloride, Clarithromycin, Azithromycin
June 23, 2005
321119
NCT00002191
Completed
Completed
A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
Conditions: Protozoan Infections; HIV Infections
Intervention: Albendazole
Conditions: Protozoan Infections; HIV Infections
Intervention: Albendazole
June 23, 2005
321120
NCT00002190
Completed
Completed
A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients
Conditions: HIV Infections
Intervention: Saquinavir, Lamivudine, Zidovudine
Conditions: HIV Infections
Intervention: Saquinavir, Lamivudine, Zidovudine
June 23, 2005
321121
NCT00002189
Completed
Completed
Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals
Conditions: Sarcoma, Kaposi; HIV Infections
Intervention: Paclitaxel
Conditions: Sarcoma, Kaposi; HIV Infections
Intervention: Paclitaxel
June 23, 2005
321122
NCT00002188
Completed
Completed
A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma
Conditions: Sarcoma, Kaposi; HIV Infections
Intervention: Alitretinoin
Conditions: Sarcoma, Kaposi; HIV Infections
Intervention: Alitretinoin
June 23, 2005
321123
NCT00002187
Completed
Completed
A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
Conditions: Cytomegalovirus Retinitis; HIV Infections
Intervention: Fomivirsen Sodium
Conditions: Cytomegalovirus Retinitis; HIV Infections
Intervention: Fomivirsen Sodium
June 23, 2005
321124
NCT00002186
Completed
Completed
Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)
Conditions: Herpes Simplex; HIV Infections
Intervention: Crofelemer, Acyclovir
Conditions: Herpes Simplex; HIV Infections
Intervention: Crofelemer, Acyclovir
June 23, 2005
321125
NCT00002185
Completed
Completed
A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
Conditions: Sarcoma, Kaposi; HIV Infections
Intervention: Nelfinavir Mesylate
Conditions: Sarcoma, Kaposi; HIV Infections
Intervention: Nelfinavir Mesylate
June 23, 2005
321126
NCT00002184
Completed
Completed
A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient
Conditions: HIV Infections
Intervention: Nelfinavir Mesylate, Levocarnitine, Adefovir Dipivoxil, Saquinavir, Lamivudine, Stavudine, Zidovudine
Conditions: HIV Infections
Intervention: Nelfinavir Mesylate, Levocarnitine, Adefovir Dipivoxil, Saquinavir, Lamivudine, Stavudine, Zidovudine
June 23, 2005
321127
NCT00002183
Completed
Completed
A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection
Conditions: HIV Infections
Intervention: Abacavir Sulfate, Amprenavir, Lamivudine, Zidovudine
Conditions: HIV Infections
Intervention: Abacavir Sulfate, Amprenavir, Lamivudine, Zidovudine
June 23, 2005
321128
NCT00002182
Completed
Completed
A Study of Megestrol Acetate in HIV-Infected Children
Conditions: HIV Infections
Intervention: Megestrol Acetate
Conditions: HIV Infections
Intervention: Megestrol Acetate
June 23, 2005
321129
NCT00002181
Completed
Completed
Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS
Conditions: Herpes Simplex; HIV Infections
Intervention: Cidofovir
Conditions: Herpes Simplex; HIV Infections
Intervention: Cidofovir
June 23, 2005
321130
NCT00002180
Completed
Completed
June 23, 2005
321131
NCT00002179
Completed
Completed
The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection
Conditions: HIV Infections
Intervention: Indinavir Sulfate, Lamivudine, Zidovudine
Conditions: HIV Infections
Intervention: Indinavir Sulfate, Lamivudine, Zidovudine
June 23, 2005
321132
NCT00002178
Completed
Completed
A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients
Conditions: HIV Infections
Intervention: Ritonavir, Nelfinavir Mesylate, Saquinavir, Delavirdine Mesylate
Conditions: HIV Infections
Intervention: Ritonavir, Nelfinavir Mesylate, Saquinavir, Delavirdine Mesylate
June 23, 2005
321133
NCT00002177
Completed
Completed
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection
Conditions: HIV Infections
Intervention: Hydroxyurea, Nelfinavir Mesylate, Stavudine, Didanosine
Conditions: HIV Infections
Intervention: Hydroxyurea, Nelfinavir Mesylate, Stavudine, Didanosine
April 13, 2011
321134
NCT00002176
Completed
Completed
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection
Conditions: HIV Infections
Intervention: Hydroxyurea, Nelfinavir Mesylate, Stavudine, Didanosine
Conditions: HIV Infections
Intervention: Hydroxyurea, Nelfinavir Mesylate, Stavudine, Didanosine
April 13, 2011
321135
NCT00002175
Completed
Completed
Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.
Conditions: HIV Infections
Intervention: Dinitrochlorobenzene
Conditions: HIV Infections
Intervention: Dinitrochlorobenzene
June 23, 2005
321136
NCT00002174
Completed
Completed
Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients
Conditions: HIV Infections
Intervention: Thalidomide
Conditions: HIV Infections
Intervention: Thalidomide
June 23, 2005
321137
NCT00002173
Completed
Completed
An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.
Conditions: HIV Infections
Intervention: HIV-1 Immunogen
Conditions: HIV Infections
Intervention: HIV-1 Immunogen
June 23, 2005
321138
NCT00002172
Completed
Completed
An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml
Conditions: HIV Infections
Intervention: HIV-1 Immunogen
Conditions: HIV Infections
Intervention: HIV-1 Immunogen
June 23, 2005
321139
NCT00002171
Completed
Completed
A Study of Viracept in HIV-Positive Women
Conditions: HIV Infections
Intervention: Nelfinavir Mesylate
Conditions: HIV Infections
Intervention: Nelfinavir Mesylate
June 23, 2005
321140
NCT00002170
Completed
Completed
A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)
Conditions: Mycobacterium Avium-Intracellulare Infection; HIV Infections
Intervention: Nelfinavir Mesylate
Conditions: Mycobacterium Avium-Intracellulare Infection; HIV Infections
Intervention: Nelfinavir Mesylate
June 23, 2005
321141
NCT00002169
Completed
Completed
A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis
Conditions: Cytomegalovirus Retinitis; HIV Infections
Intervention: Nelfinavir Mesylate
Conditions: Cytomegalovirus Retinitis; HIV Infections
Intervention: Nelfinavir Mesylate
June 23, 2005
321142
NCT00002168
Completed
Completed
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
Conditions: HIV Infections
Intervention: Indinavir Sulfate, Lamivudine, Stavudine, Zidovudine, Didanosine
Conditions: HIV Infections
Intervention: Indinavir Sulfate, Lamivudine, Stavudine, Zidovudine, Didanosine
October 1, 2007
321143
NCT00002167
Completed
Completed
Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.
Conditions: Sarcoma, Kaposi; HIV Infections
Intervention: Tin Ethyl Etiopurpurin
Conditions: Sarcoma, Kaposi; HIV Infections
Intervention: Tin Ethyl Etiopurpurin
June 23, 2005
321144
NCT00002166
Completed
Completed
An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease
Conditions: HIV Infections
Intervention: Nevirapine
Conditions: HIV Infections
Intervention: Nevirapine
June 23, 2005
321145
NCT00002165
Completed
Completed
June 23, 2005
321146
NCT00002164
Completed
Completed
Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants
Conditions: HIV Infections
Intervention: Nelfinavir Mesylate
Conditions: HIV Infections
Intervention: Nelfinavir Mesylate
June 23, 2005
321147
NCT00002163
Completed
Completed
A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex
Conditions: AIDS Dementia Complex; HIV Infections
Intervention: Abacavir Sulfate
Conditions: AIDS Dementia Complex; HIV Infections
Intervention: Abacavir Sulfate
June 23, 2005
321148
NCT00002162
Completed
Completed
A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs
Conditions: HIV Infections
Intervention: Saquinavir, Lamivudine, Stavudine, Zidovudine, Zalcitabine, Didanosine
Conditions: HIV Infections
Intervention: Saquinavir, Lamivudine, Stavudine, Zidovudine, Zalcitabine, Didanosine
June 23, 2005
321149
NCT00002161
Completed
Completed
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3
Conditions: HIV Infections
Intervention: Adefovir Dipivoxil
Conditions: HIV Infections
Intervention: Adefovir Dipivoxil
June 23, 2005
321150
NCT00002160
Completed
Completed
A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain
Conditions: HIV Infections; Cancer; Pain
Conditions: HIV Infections; Cancer; Pain
June 23, 2005
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6403 6404 6405 6406 6407 6408 6409 6410 6411 6412 6413 6414 6415 6416 6417 6418 6419 6420 6421 6422 6423 6424 6425 6426 6427 6428 6429 6430 6431 6432 6433 6434 6435 6436 6437 6438 6439 6440 6441 6442 6443 … 6470 6471 6472 6473 6474 6475 6476 6477 6478 6479 6480 6481 6482 6483 6484 6485 6486 6487 6488 6489 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.